Cat: IPD-X41684

Recombinant Staphylococcus aureus cap5A Protein ,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    cap5A

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Species

    Staphylococcus aureus

  • Source

    E. coli

  • Tag

    N- His

  • Purity

    Greater than 90% as determined by SDS-PAGE.

  • Uniprot

    P95695

  • Expression Region

    1-222aa

  • Molecular Weight

    26.4 kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

Cap5A, an important protein found in certain bacterial species, has garnered significant interest in the field of microbiology and biotechnology due to its crucial role in virulence and adaptation. This protein is primarily associated with the pathogenicity of bacterial strains, influencing their ability to adhere to host tissues and evade the immune response. Research into Cap5A has revealed its involvement in forming capsular structures, which serve as protective barriers against host defense mechanisms, thereby enhancing the survival and infectious capacity of bacteria. Understanding the molecular mechanisms underlying Cap5A's function provides valuable insights into bacterial pathogenesis and opens up potential avenues for developing novel therapeutic strategies, including vaccines and antibody treatments. Furthermore, the recombinant production of Cap5A offers opportunities for studying its structure and function in detail, facilitating the exploration of its applications in biomedicine and vaccine development. As antibiotic resistance becomes a growing concern, targeting virulence factors like Cap5A might represent a promising approach to combat bacterial infections. Thus, ongoing research into the recombinant expression and functional characterization of Cap5A is crucial for advancing our understanding of bacterial behavior and developing effective interventions.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US